Timing of Active Void Trials After Urogynecologic Procedures
Status
Conditions
Treatments
Details and patient eligibility
About
The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogynecologic surgery.
Patient will be randomized to two arms prior to scheduled surgery. During the active void trial, women will be allotted up to 30 minutes or up to 60 minutes to void depending on respective randomization.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Women undergoing a urogynecologic surgery at Tampa General Hospital and who are seen preoperatively at the University of South Florid Urogynecology clinic
- Women undergoing a urogynecologic surgery where a postoperative active void trial is indicated
- Planned for same day surgery
- Women able to consent for themselves
- Speak English and/or Spanish as preferred language
Exclusion criteria
- Imprisoned patients
- Females under the age of 18 years old
- Women who are unable or unwilling to consent to participation
- Women who are planning to stay inpatient overnight
- Women with history of urinary retention or neurogenic bladder
- Women undergoing procedure that is not standard of care to perform a void trial (includes sacral neuromodulation, botox to the pelvic floor, cystoscopy with hydrodistension, urethral bulking, etc)
Trial design
Primary purpose
Allocation
Interventional model
Masking
231 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Simone Fertel, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal